ArcticZymes Technologies files new patent application within RNA based therapeutics
Tromsø, Norway, 16[th] of March 2023 - ArcticZymes Technologies ASA (OSE: AZT) has filed a new patent application within the field of RNA based therapeutics. The patent application covers a new nuclease enzyme composition and method-of-use in the processing and analysis of RNA for therapeutic purposes. RNA therapy is the treatment or prevention of diseases by using modified RNA molecules.Developing RNA for therapeutic purposes is challenging and time consuming and requires high-end instrumentation. The new enzyme can ease and improve the analytical processes for therapeutic RNA for both